Bought
Maintained
Sold
Other funds holding GSK
JEST
VeraBank's GSK Position: Q2 2026 in Review
VeraBank reduced its GSK (GSK) stake by 16% in Q2 2026, selling an estimated $199K and leaving 20,501 shares worth $1.07M. The position accounts for 0.18% of the portfolio, ranked #78.
VeraBank first reported a position in GSK in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.34M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- VeraBank held 20,501 shares of GSK worth $1.07M as of Q2 2026.
- VeraBank sold 3,768 GSK shares in Q2 2026, an estimated $199K.
- GSK made up 0.18% of VeraBank's portfolio in Q2 2026, its #78 holding.
- VeraBank first reported a position in GSK in Q2 2025 and has held it in 5 quarters since.
- VeraBank's GSK position peaked at $1.34M in Q1 2026.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on VeraBank's 13F filing for Q2 2026, filed 6 Aug 2026.